First Report of Symmetrical Drug-related Intertriginous and Flexural Exanthema (SDRIFE or Baboon Syndrome) After Erenumab Application for Migraine Prevention-Reference-Cited by-同舟云学术

First Report of Symmetrical Drug-related Intertriginous and Flexural Exanthema (SDRIFE or Baboon Syndrome) After Erenumab Application for Migraine Prevention

Published:2022-07-31 Issue:4 Volume:11 Page:1483-1491
ISSN:2193-8237
Container-title:Pain and Therapy
language:en
Short-container-title:Pain Ther

Author:

Göbel Carl H.^ORCID,Heinze Axel,Karstedt Sarah,Cirkel Anna,Münte Thomas F.,Göbel Hartmut

Publisher

Springer Science and Business Media LLC

Subject

Anesthesiology and Pain Medicine,Neurology (clinical)

Link

https://link.springer.com/content/pdf/10.1007/s40122-022-00417-6.pdf

Reference48 articles.

1. Bulur I, Keseroglu HO, Saracoglu ZN, et al. Symmetrical drug-related intertriginous and flexural exanthema (baboon syndrome) associated with infliximab. J Dermatol Case Rep. 2015;9:12–4.

2. De Risi-Pugliese T, Barailler H, Hamelin A, et al. Symmetrical drug-related intertriginous and flexural exanthema: a little-known drug allergy. J Allergy Clin Immunol Pract. 2020;8(3185–3189): e3184.

3. Harbaoui S, Litaiem N. Symmetrical drug-related intertriginous and flexural exanthema. In: StatPearls. Treasure Island; 2022.

4. Lima Miranda O, Martins J, Almeida A, et al. Symmetrical drug-related intertriginous and flexural exanthema (baboon syndrome). Eur J Case Rep Intern Med. 2021;8: 003029.

5. Neema S, Shaw SC, Gopalakrishnan S. Symmetrical drug-related intertriginous and flexural exanthema. Indian Pediatr. 2020;57:1093.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative proteomics reveals CLR interactome in primary human cells;Journal of Biological Chemistry;2024-06

3. Hypersensitivity to galcanezumab with tolerance to erenumab and fremanezumab;The Journal of Allergy and Clinical Immunology: In Practice;2023-08

4. Erenumab;Reactions Weekly;2023-04-22

5. Novel protein interaction network of human calcitonin receptor-like receptor revealed by label-free quantitative proteomics;2023-04-19